GEA Niro
Spray drying is a technique preferred by a growing number of pharmaceutical companies to produce better drugs. This ultra-fast and gentle drying technology offers unique possibilities of producing powders with advanced properties.
Several companies are already benefiting from the technology as an ‘enabling technology’ — to improve the performance of poorly soluble APIs by producing an amorphous solid dispersion, to obtain controlled release or taste masking or to produce advanced powders with specific properties. GEA Process Engineering — the company behind GEA Niro spray drying technology — is a leading provider of spray drying technology to the pharmaceutical industry and one of the few companies that offers a full range of spray drying units as well as spray drying services. Services cover the complete development cycle, from the initial proof of concept tests where only a few ml of material is available to full-scale production of clinical trial materials and commercial products under cGMP conditions.
GEA Process Engineering’s Pharmaceutical Spray Drying facility in Denmark is available for product and process development and is available for contract spray drying under cGMP conditions. The benefits of working with GEA are two-fold, allowing customers to take full advantage of the company’s vast expertise in spray drying technology gained from decades of experience and to save investments in spray drying facilities until the first approvals are in place and the product is ready for commercial production.
GEA Process Engineering, +45 3954 5454, gea-niro.pharma@gea.com, www.niro.com.